ID   APOA2_RAT               Reviewed;         102 AA.
AC   P04638;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   24-JUL-2024, entry version 165.
DE   RecName: Full=Apolipoprotein A-II;
DE            Short=Apo-AII;
DE            Short=ApoA-II;
DE   AltName: Full=Apolipoprotein A2;
DE   Contains:
DE     RecName: Full=Proapolipoprotein A-II;
DE              Short=ProapoA-II;
DE   Flags: Precursor;
GN   Name=Apoa2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3084795; DOI=10.1016/0022-2836(86)90436-5;
RA   Luo C.-C., Li W.-H., Moore M.N., Chan L.;
RT   "Structure and evolution of the apolipoprotein multigene family.";
RL   J. Mol. Biol. 187:325-340(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12-102.
RX   PubMed=3093619;
RA   Nagashima M., Morris G., Howlett G., Fidge N., Schreiber G.;
RT   "Amino acid sequence of rat apolipoprotein A-II deduced from the nucleotide
RT   sequence of cloned cDNA.";
RL   J. Lipid Res. 27:706-712(1986).
CC   -!- FUNCTION: May stabilize HDL (high density lipoprotein) structure by its
CC       association with lipids, and affect the HDL metabolism.
CC   -!- SUBUNIT: Monomer. Interacts with NAXE and NDRG1 (By similarity).
CC       {ECO:0000250|UniProtKB:P02652}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P02652}.
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- SIMILARITY: Belongs to the apolipoprotein A2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03468; CAA27185.1; -; mRNA.
DR   EMBL; M28615; AAA40750.1; -; mRNA.
DR   PIR; A24846; A24846.
DR   RefSeq; NP_037244.1; NM_013112.1.
DR   RefSeq; XP_006250300.1; XM_006250238.2.
DR   RefSeq; XP_006250301.1; XM_006250239.2.
DR   AlphaFoldDB; P04638; -.
DR   SMR; P04638; -.
DR   STRING; 10116.ENSRNOP00000004662; -.
DR   iPTMnet; P04638; -.
DR   PhosphoSitePlus; P04638; -.
DR   PaxDb; 10116-ENSRNOP00000004662; -.
DR   Ensembl; ENSRNOT00000004662.5; ENSRNOP00000004662.1; ENSRNOG00000003500.5.
DR   Ensembl; ENSRNOT00055037906; ENSRNOP00055030947; ENSRNOG00055022062.
DR   Ensembl; ENSRNOT00060044743; ENSRNOP00060037094; ENSRNOG00060025852.
DR   Ensembl; ENSRNOT00065037198; ENSRNOP00065030006; ENSRNOG00065021869.
DR   GeneID; 25649; -.
DR   KEGG; rno:25649; -.
DR   UCSC; RGD:2131; rat.
DR   AGR; RGD:2131; -.
DR   CTD; 336; -.
DR   RGD; 2131; Apoa2.
DR   eggNOG; ENOG502SVYZ; Eukaryota.
DR   GeneTree; ENSGT00390000003306; -.
DR   HOGENOM; CLU_157351_0_0_1; -.
DR   InParanoid; P04638; -.
DR   OMA; LTICSFE; -.
DR   OrthoDB; 4610750at2759; -.
DR   PhylomeDB; P04638; -.
DR   TreeFam; TF338165; -.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   Reactome; R-RNO-8963888; Chylomicron assembly.
DR   Reactome; R-RNO-8963901; Chylomicron remodeling.
DR   Reactome; R-RNO-975634; Retinoid metabolism and transport.
DR   PRO; PR:P04638; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000003500; Expressed in liver and 18 other cell types or tissues.
DR   GO; GO:0042627; C:chylomicron; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0034364; C:high-density lipoprotein particle; ISO:RGD.
DR   GO; GO:0034366; C:spherical high-density lipoprotein particle; ISO:RGD.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; ISO:RGD.
DR   GO; GO:0034190; F:apolipoprotein receptor binding; ISO:RGD.
DR   GO; GO:0015485; F:cholesterol binding; ISO:RGD.
DR   GO; GO:0120020; F:cholesterol transfer activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; ISO:RGD.
DR   GO; GO:0008035; F:high-density lipoprotein particle binding; ISO:RGD.
DR   GO; GO:0070653; F:high-density lipoprotein particle receptor binding; ISO:RGD.
DR   GO; GO:0055102; F:lipase inhibitor activity; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; ISO:RGD.
DR   GO; GO:0005319; F:lipid transporter activity; ISO:RGD.
DR   GO; GO:0031210; F:phosphatidylcholine binding; ISO:RGD.
DR   GO; GO:0060228; F:phosphatidylcholine-sterol O-acyltransferase activator activity; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IDA:RGD.
DR   GO; GO:0033344; P:cholesterol efflux; ISO:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0030301; P:cholesterol transport; IDA:RGD.
DR   GO; GO:0046340; P:diacylglycerol catabolic process; ISO:RGD.
DR   GO; GO:0034380; P:high-density lipoprotein particle assembly; ISO:RGD.
DR   GO; GO:0034384; P:high-density lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; ISO:RGD.
DR   GO; GO:0006869; P:lipid transport; ISO:RGD.
DR   GO; GO:0042157; P:lipoprotein metabolic process; ISO:RGD.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; ISO:RGD.
DR   GO; GO:0060621; P:negative regulation of cholesterol import; ISO:RGD.
DR   GO; GO:0032375; P:negative regulation of cholesterol transport; ISO:RGD.
DR   GO; GO:0002719; P:negative regulation of cytokine production involved in immune response; ISO:RGD.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; ISO:RGD.
DR   GO; GO:0010903; P:negative regulation of very-low-density lipoprotein particle remodeling; ISO:RGD.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; ISO:RGD.
DR   GO; GO:0009395; P:phospholipid catabolic process; ISO:RGD.
DR   GO; GO:0033700; P:phospholipid efflux; ISO:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISS:UniProtKB.
DR   GO; GO:0050996; P:positive regulation of lipid catabolic process; ISO:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0030300; P:regulation of intestinal cholesterol absorption; ISO:RGD.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0043691; P:reverse cholesterol transport; ISO:RGD.
DR   GO; GO:0034370; P:triglyceride-rich lipoprotein particle remodeling; ISO:RGD.
DR   Gene3D; 6.10.250.100; -; 1.
DR   InterPro; IPR006801; ApoA-II.
DR   InterPro; IPR036172; ApoA-II_sf.
DR   PANTHER; PTHR11027; APOLIPOPROTEIN A-II; 1.
DR   PANTHER; PTHR11027:SF0; APOLIPOPROTEIN A-II; 1.
DR   Pfam; PF04711; ApoA-II; 1.
DR   SUPFAM; SSF82936; Apolipoprotein A-II; 1.
PE   2: Evidence at transcript level;
KW   Cleavage on pair of basic residues; HDL; Lipid transport; Oxidation;
KW   Reference proteome; Secreted; Signal; Transport.
FT   SIGNAL          1..18
FT   CHAIN           19..102
FT                   /note="Proapolipoprotein A-II"
FT                   /id="PRO_0000425360"
FT   CHAIN           24..102
FT                   /note="Apolipoprotein A-II"
FT                   /evidence="ECO:0000250|UniProtKB:P09813"
FT                   /id="PRO_0000002012"
FT   MOD_RES         49
FT                   /note="Methionine sulfoxide"
FT                   /evidence="ECO:0000250|UniProtKB:P02652"
SQ   SEQUENCE   102 AA;  11439 MW;  94A29508DFE7A813 CRC64;
     MKLLAMVALL VTICSLEGAL VRRQAAETDV QTLFSQYLQS LTDYGKDLME KAQPSEIQNQ
     AKAYFQNAQE RLTPFVQRTG TNLMDFLSRL MSPEEKPAPA AK
//
